Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to ...

KGaA (MRK:GR) (OTC: MKGAF) stock from Overweight to Equalweight and reduced its price target from EUR190.00 to EUR160.00. The downgrade reflects a shift in the investment firm's perspective on the ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

JOHNSON CITY, Tenn., Feb. 3, 2025 /PRNewswire/ -- LabConnect, a leading provider of central lab services and functional ...

They include U.S. government securities, municipals, mortgage and asset-backed, foreign bonds, and corporate bonds. In a well-diversified investment portfolio, highly-rated corporate bonds with ...

Brendan Hoffman Expected to Become CEO of Vince Holding Corp. NEW YORK, January 22, 2025--(BUSINESS WIRE)--Vince Holding Corp., (NYSE: VNCE) ("VNCE" or the "Company"), a global contemporary ...